ProteiNext 2025: Gene Therapy Analytical Development Symposium
Welcome to ProteiNext Symposium, proudly brought to you by Bio-Techne. With a focus on protein analysis, ProteiNext is an annual symposium that offers a platform for sharing insights, overcoming challenges, and driving meaningful progress in the field.
This year, we shine a spotlight on Gene Therapy Analytical Development - a field that is transforming the landscape of medicine and treatment. We invite industry experts to join us to discuss the complexities and challenges in gene therapy analytical development. The sessions will cover topics such as the development of robust analytical platforms, challenges in gene transfer and delivery systems, protein characterization in gene therapy products, and regulatory considerations that impact the field. Special emphasis will be placed on optimizing analytical strategies for gene therapy quality control, as well as ensuring consistency, safety, and efficacy.
Join us as we embark on a journey of exploration, innovation, and discovery at ProteiNext. Together, let's push the boundaries of possibility and shape the future of protein science.
Key Learnings:
- Gain insights into the latest analytical strategies for critical quality attribute analysis for gene therapy development, including protein characterization, vector stability assessment, and delivery system optimization.
- Learn from industry experts tackling real-world challenges in gene therapy analytical development and explore innovative solutions driving the field forward.
- Understand regulatory considerations and quality control measures essential for ensuring consistency, safety, and efficacy in gene therapy development.
Presenter: Ana Carreras Gonzalez (R&D Analytical Development Scientist, Viralgen)
Presenter: Benjamin Hall (Senior Scientist, Tessera Therapeutics)
Presenter: Chris Heger, Ph.D. (Director, Application Sciences, Bio-Techne)
Presenter: David Hermanson (Principal Scientist, Cell & Gene Therapy, Bio-Techne)
Presenter: Gabriel Vasquez (Specialist II, MilliporeSigma)
Presenter: Louis Szeponik, Ph.D. (Senior Scientist, Discovery Imaging Sciences, AstraZeneca, Sweden)
Presenter: Nicolas Tricaud, Ph.D. (Co-founder, CEO/CSO, Nervosave Therapeutics)
Presenter: Priyalakshmi Panikker, Ph.D. (Asst. Principal Investigator, GROW Laboratory, Narayana Nethralaya)
Presenter: Ryan McComb, Ph.D. (Product Manager, Cellular Analysis, Bio-Techne)
Presenter: William Wood (Analytical Lead, Cell and Gene Therapy Catapult)
Presenter: Zusen Weng (Sr. Scientist, Applications and Business Development, Bio-Techne China)
